Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
Abstract Background Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low card...
Main Authors: | Jose Luis Guerrero Orriach, I. Navarro Arce, P. Hernandez Rodriguez, A. Raigón Ponferrada, A. Malo Manso, M. Ramirez Aliaga, A. Ramirez Fernandez, J. J. Escalona Belmonte, I. Bellido Estevez, A. Gomez Luque, R. Barrera Serrano, C. S. Toledo Medina, M. Rubio Navarro, J. Cruz Mañas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12871-019-0888-2 |
Similar Items
-
Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
by: Jose L. Guerrero-Orriach, et al.
Published: (2020-08-01) -
CARDIAC PROTECTIVE INOTROPIC THERAPY – OPPORTUNITIES AND PROSPECTIVE OF USING LEVOSIMENDAN IN CARDIAC SURGERY
by: V. V. Pasyuga, et al.
Published: (2018-01-01) -
Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery
by: Meiling Zhao, et al.
Published: (2025-01-01) -
Effect of Levosimendan on Low Cardiac Output Syndrome After Pericardiectomy
by: Fang L, et al.
Published: (2024-12-01) -
Influence of timing of Levosimendan administration on outcomes in cardiac surgery
by: Fridtjof Schiefenhövel, et al.
Published: (2023-07-01)